Table 4. Primary Analyses:
Thalamic Volume* | Lesion volume* | NAWM FA MD* | Gray matter volume* | |||
---|---|---|---|---|---|---|
Diet quality score |
Quartile | Mean (SD) | Beta** (95% CI) | Beta** (95% CI) | Beta** (95% CI) | Beta** (95% CI) |
MIND | Q1 | 6.47 (1.03) | 0.00 [ref] | 0.00 [ref] | 0.00 [ref] | 0.00 [ref] |
Q2 | 8.29 (0.25) | 0.62 (-0.08, 1.33) | -0.32 (-0.87, 0.23) | 0.52 (0.15, 0.89) | 4.46 (-12.66, 21.58) | |
Q3 | 9.28 (0.25) | 1.16 (0.41, 1.91) | -0.29 (-0.88, 0.30) | 0.36 (-0.04, 0.76) | 14.75 (-3.41, 32.90) | |
Q4 | 10.68 (0.81) | 1.03 (0.26, 1.79) | -0.11 (-0.72, 0.49) | 0.40 (-0.00, 0.80) | 7.17 (-11.43, 25.78) | |
P for linear trend across quartiles | 0.002 | 0.65 | 0.08 | 0.24 |
Units for volumetric measures are presented as mL. T2 lesion volume was log-transformed to improve normality; NAWM FA MD: Normal appearing white matter fractional anisotropy, mean diffusivity.
Adjusted for age, sex, race, ethnicity, socio-economic status, physical activity, BMI, smoking status, disease duration, disease modifying therapy use and class, and total energy intake.